COMMUNIQUÉS West-GlobeNewswire

The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship
22/07/2026
New physician fellowship, leadership of the Academy of Exercise Medicine, and groundbreaking scientific research position The Lundquist Institute at the forefront of the emerging field of Exercise Medicine. Los Angeles [...]
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
22/07/2026
HUNTSVILLE, Ala., July 22, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancing its proprietary POZ Platform ™ drug [...]
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
22/07/2026
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market [...]
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
FREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the second quarter of 2026 after [...]
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
22/07/2026
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, [...]
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/07/2026
FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective July 17, 2026, it granted stock options to purchase [...]
Fractyl Health to Participate in Upcoming Investor Events
22/07/2026
BURLINGTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity [...]
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the [...]
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
HOLLISTER, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Egg Medical Declares New Era in Fluoroscopy Lab Safety Following Joint Consensus Statement
22/07/2026
As major medical societies call for mandatory adoption of Enhanced Radiation Protection Devices (ERPDs), the EggNest® Complete system emerges as the definitive solution to protect the entire clinical team MINNEAPOLIS, [...]
Serenity Medical’s River Stent™ Demonstrates Sustained 4- to 5-Year Benefits in Patients with Idiopathic Intracranial Hypertension (IIH), Presented at SNIS Annual Meeting in Late-Breaking Session
22/07/2026
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option MAPLE GROVE, Minn., July 22, 2026 (GLOBE NEWSWIRE) -- Serenity Medical , a NeuroTechnology Investors (NTI [...]
The Healing Well Method Launches Chronic Illness Education Initiative to Empower Women with Chronic Illness
22/07/2026
Fort Lauderdale, FLORIDA, July 22, 2026 (GLOBE NEWSWIRE) -- The Healing Well Method today announced the launch of its Chronic Illness Education Initiative, a new educational program designed to help women living with [...]
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its second quarter 2026 financial results will be released on Wednesday, August 5, 2026. Starting at 5 [...]
NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
22/07/2026
Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services, pharmaceutical access, lab testing, institutional partnerships, [...]
Spryte Medical Completes INSYTE Trial Enrollment
22/07/2026
FDA-approved IDE study of the company’s neuro-optical coherence tomography nOCT™ Imaging System completes enrollment, representing a significant step toward regulatory submission for diagnostic use in intracranial [...]
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026
22/07/2026
CORRECTIVE STATEMENT Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026, published on July 9, 2026 Paris, July 22, 2026 This corrective statement is [...]

Pages